ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,930Medicare Part D Prescriptions Filled, Including Refills

Rank: 662 out of 3647

$609K Total Retail Price of All Prescriptions

Rank: 756 out of 3647

1,024 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 1,024 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 11,239 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
ENOXAPARIN SODIUM 496 484 10 1 275
LISINOPRIL 443 416 2 4
AMLODIPINE BESYLATE 351 338 3 2
LEVOTHYROXINE SODIUM 336 313 4 5
METOPROLOL TARTRATE 313 295 5 7
OMEPRAZOLE 298 280 6 3
PANTOPRAZOLE SODIUM 297 285 7 38
SIMVASTATIN 287 274 8 1
FUROSEMIDE 237 232 9 8
METFORMIN HCL 205 184 10 6
CITALOPRAM HBR 202 191 11 25
TEMAZEPAM 186 175 12 47
CLOPIDOGREL 168 158 13 26
PRAVASTATIN SODIUM 163 157 14 16
FAMOTIDINE 137 120 15 61
PLAVIX 134 133 16 39
DONEPEZIL HCL 131 131 17 30
WARFARIN SODIUM 130 129 18 15
ESCITALOPRAM OXALATE 128 119 19 65
LOSARTAN POTASSIUM 124 123 20 11
NAPROXEN 124 117 20 70
ATENOLOL 120 114 22 10
POTASSIUM CHLORIDE 119 115 23 24
CARVEDILOL 119 113 23 20
DIGOXIN 115 115 25 51
CIPROFLOXACIN HCL 112 102 26 53
ALPRAZOLAM 111 103 27 31
ZOLPIDEM TARTRATE 110 90 28 14
PAROXETINE HCL 107 96 29 60
TRAMADOL HCL 105 102 30 22
HYDROCHLOROTHIAZIDE 103 91 31 9
CLONIDINE HCL 103 97 31 46
GABAPENTIN 97 87 33 17
RISPERIDONE 93 84 34 83
NAMENDA 90 90 35 49
ALBUTEROL SULFATE 89 86 36 157
IPRATROPIUM BROMIDE 80 77 37 210
QUETIAPINE FUMARATE 78 77 38 89
CRESTOR 71 64 39 19
TAMSULOSIN HCL 71 69 39 28
METOPROLOL SUCCINATE 69 59 41 18
LANTUS 66 62 42 59
TRIAMTERENE-HCTZ 66 63 42 58
LEVOFLOXACIN 64 62 44 87
CARBIDOPA-LEVODOPA 63 63 45 127
SINGULAIR 63 48 45 90
DILTIAZEM 24HR ER 62 58 47 164
HEPARIN SODIUM 61 61 48 351
GLYBURIDE 60 60 R 49 54
FINASTERIDE 59 59 50 66
DIOVAN 59 59 50 40
KETOCONAZOLE 57 42 52 132
LACTULOSE 57 50 52 128
MECLIZINE HCL 56 56 54 85
CLONAZEPAM 55 44 55 146
RANITIDINE HCL 54 53 56 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 26, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.